FDA Strikes Out CorMedix's DefenCath Application

The FDA has issued a Complete Response Letter for CorMedix Inc's (NASDAQ: CRMD) marketing application seeking approval for DefenCath (taurolidine/heparin catheter lock solution) for catheter-related bloodstream infections.

  • FDA noted concerns at the third-party manufacturing facility after reviewing records, though the agency did not specify the issues.
  • CorMedix will request a meeting with the FDA, which is estimated to happen by mid-April.
  • The company intends to obtain a plan to resolve the problems when the FDA informs the specific concerns.
  • Additionally, FDA requires a manual extraction study to demonstrate that the labeled volume can be consistently withdrawn from the vials despite an existing in-process control to demonstrate fill volume within specifications.
  • FDA did not request additional clinical data and did not identify any efficacy or safety data deficiencies.
  • The draft labeling discussed with the FDA added that the initial approval would be for the limited population of patients with kidney failure receiving chronic hemodialysis through a central venous catheter.
  • Price Action: CRMD shares trading is halted, to resume at 9 am ET.

Posted In: bloodstream infectionsBiotechNewsHealth CareSmall CapFDAGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.